Back to VRDN
J. Safra Sarasin Holding AG → VRDN
J. Safra Sarasin Holding AG VRDN Position History
Viridian Therapeutics, Inc. • Healthcare
Quarters held
5
Latest value
$2.4M
Q3 2026
Peak value
$2.7M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $1.1M |
| Q4 2025 | $2.7M |
| Q1 2026 | $1.4M |
| Q2 2026 | $2M |
| Q3 2026 | $2.4M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $2.4M | 117.6K | — | — |
| Q2 2026 | $2M | 107.8K | — | — |
| Q1 2026 | $1.4M | 73.1K | — | — |
| Q4 2025 | $2.7M | 88.3K | — | — |
| Q3 2025 | $1.1M | 51.7K | — | — |
Other funds holding VRDN
$112.5M
$112.5M
$91.4M
$46.7M
$42.8M